From penetrating solid tumors to new success rates for de novo design, the next wave of antibody therapies aims to transform the clinic.

Researchers in the College of Agriculture, Health and Natural Resources have developed a novel line of bovine embryonic stem ...

Polaryx believes the addition of Dr. Berger, Mr. Braun, and Dr. Ryan brings valuable expertise across scientific research, ...

Plant cell cultures are an attractive alternative to cultivating whole plants for obtaining natural compounds, but many ...

The Super Bowl-bound Patriots and Seahawks got their mojo back. But their home cities are on an economic losing streak.

Nearly 100 biotechs went public amid the industry’s IPO frenzy in 2021, driven by an influx of pandemic-driven investments. But many of those companies have little to show investors.

AI has interrupted a deflating equity bubble, delaying the usual bust while increasing the risks that historically follow ...

A trio of new vaccines could provide a lifeline in the fight against cholera at a time when cases are soaring worldwide, experts believe.

The strongest robotics growth is expected to be in manufacturing, logistics and warehousing, retail and hospitality, agriculture and healthcare. By 2027–2028, corporations that fail to adopt robotics ...

Cleveland Diagnostics, a commercial-stage oncology company, announced it named Michael Iskra as its new CEO on Jan. 26. Iskra ...